EC17 (Folate-FITC)

DRUG2 trials

Sponsors

Endocyte

Conditions

CancerRenal Cell Carcinoma

Phase 1

Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer

CompletedNCT00329368

Start: 2005-09-30End: 2008-06-30Updated: 2012-03-09

Phase 2

A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma

TerminatedNCT00485563

EndocyteRenal Cell Carcinoma

Start: 2007-06-30End: 2009-03-31Updated: 2012-03-08